CSIMarket
 
Iteos Therapeutics Inc   (ITOS)
 

Iteos Therapeutics Inc declared top-line has dropped by -77.587 %, amid the fiscal time-frame ending December 31 2022

company announced fourth quarter of 2022 operating profit of $17.383 millions


Published Mar 16 2023
CSIMarket Team / CSIMarket.com


pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_CommonsFor the fourth quarter of 2022 ITOS income fell sharply by -87.3 % of $0.54 per share compare to $4.26 a year ago and earnings per share truly advanced by 1703.04 % from $0.03 per share from the preceding reporting period.

Revenues dropped sharply by -77.587 % to $53.91 millions from $240.50 millions in the comparable reporting period a year ago and sequentially Revenue doubled by 176.62 % from $19.49 millions.




Net earnings of $20.453 millions in the fourth quarter of 2022 fell by -88.94 % from $184.872 millions in the corresponding period a year before. Looking further into fourth quarter of 2022 Iteos Therapeutics Inc 's profitability, operating margin mitigated to 32.25%, and net margin shrank to 37.94%.
Operating earnings, fell -91.86% to $17.383 millions, squeezing Iteos Therapeutics Inc 's operating margin to 32.25%, from 88.78% in the fourth quarter of 2021. Looking further into Iteos Therapeutics Inc s' results for the fiscal 12 Months 2022, ITOS declared Revenues of $267.63 millions and net earnings of $96.65 millions.

Biotechnology & Pharmaceuticals company voiced also, that Income per share faded by -54.93 % to $2.56 per share from $5.68 in the preceding fiscal 12 Months , and contributedRevenues fell by -22.38 % from $344.78 millions a year ago.

Iteos Therapeutics Inc is expected to report next financial recent numbers on May 11, 2023.



Iteos Therapeutics Inc's Executive Officers

Iteos Therapeutics Inc's Income per Employee



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com